[
  {
    "ts": null,
    "headline": "Insulet names new CFO; Dexcom CEO on leave",
    "summary": "Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.",
    "url": "https://finnhub.io/api/news?id=b3216ecadec11dae3881dddea73f8e9c0eb4ce0a0a8ae2e75808261061f1246b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758026203,
      "headline": "Insulet names new CFO; Dexcom CEO on leave",
      "id": 136773285,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.",
      "url": "https://finnhub.io/api/news?id=b3216ecadec11dae3881dddea73f8e9c0eb4ce0a0a8ae2e75808261061f1246b"
    }
  },
  {
    "ts": null,
    "headline": "Medical device maker Insulet taps industry veteran Flavia Pease as CFO",
    "summary": "Insulet also said it expects to exceed its previous third-quarter total revenue forecast of 22% to 25%, driven by strong new customers for its wearable insulin pumps in both U.S. and international markets.  Pease, an industry veteran, had held the role of finance chief at contract research firm Charles River Laboratories for three years.",
    "url": "https://finnhub.io/api/news?id=7be137b16b27cf406267f578d34b21cd40708bb9da11b77d3ce6c9ef26160a57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758025509,
      "headline": "Medical device maker Insulet taps industry veteran Flavia Pease as CFO",
      "id": 136773286,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet also said it expects to exceed its previous third-quarter total revenue forecast of 22% to 25%, driven by strong new customers for its wearable insulin pumps in both U.S. and international markets.  Pease, an industry veteran, had held the role of finance chief at contract research firm Charles River Laboratories for three years.",
      "url": "https://finnhub.io/api/news?id=7be137b16b27cf406267f578d34b21cd40708bb9da11b77d3ce6c9ef26160a57"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Announces CFO Transition",
    "summary": "ACTON, Mass., September 16, 2025--Insulet Corporation (NASDAQ: PODD) (\"Insulet\" or the \"Company\"), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor to Insulet to ensure a smooth transition.",
    "url": "https://finnhub.io/api/news?id=bce0e65a7926a30992cc172bf93e67257ba74e4a3e2463efdff705a4c9fb2532",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758024000,
      "headline": "Insulet Announces CFO Transition",
      "id": 136773903,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "ACTON, Mass., September 16, 2025--Insulet Corporation (NASDAQ: PODD) (\"Insulet\" or the \"Company\"), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor to Insulet to ensure a smooth transition.",
      "url": "https://finnhub.io/api/news?id=bce0e65a7926a30992cc172bf93e67257ba74e4a3e2463efdff705a4c9fb2532"
    }
  }
]